» Articles » PMID: 20080915

Chronic Conditions and Health Problems in Rheumatic Diseases: Comparisons with Rheumatoid Arthritis, Noninflammatory Rheumatic Disorders, Systemic Lupus Erythematosus, and Fibromyalgia

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2010 Jan 19
PMID 20080915
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To describe and compare the prevalence of lifetime and current self-reported comorbidity and associated quality of life in 4 rheumatic diseases, and to investigate comorbid conditions in light of the overlap between the index condition and comorbid conditions (CC), and in the context of symptom-type diagnoses.

Methods: We studied comorbidity in 11,704 patients with fibromyalgia (FM), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and noninflammatory rheumatic disorders (NIRD). Patients completed semiannual self-reports relating to 22 present and past illnesses and completed the EuroQol (EQ-5D) utility index.

Results: CC were most common in FM, followed by SLE. FM comorbidity was dominated by depression, mental illness, and symptom-type comorbidity (e.g., gastrointestinal and genitourinary disorders). In SLE, there were substantial increases in hypertension, depression, cataract, fractures, and cardiovascular and cerebrovascular, neurologic, lung, gall bladder and endocrine disorders compared with RA. Any current CC reduced the EQ-5D utility by 0.08 to 0.16 units. The lowest EQ-5D score was noted for current psychiatric illness (0.55) and current depression (0.60).

Conclusion: Four patterns of comorbidity emerged: that associated with aging; that associated with aging but enhanced by the index condition, as in SLE and cardiovascular disease; comorbidity that is part of the symptoms complex of the index condition; and CC that represent lifetime traits or manifestations of the underlying illness. Depression was the most strongly associated correlate of EQ-5D quality of life, and current depression was present in about 15% of patients with RA or NIRD and 34% to 39% of those with SLE and FM.

Citing Articles

Knowledge, Attitude and Practice Regarding Nonsteroidal Anti-inflammatory Drugs and Corticosteroids Use Among Patients With Chronic Rheumatology Condition: A Cross-Sectional Study From Vietnam.

Nguyen H, Nguyen Q, Ha K, Le Q, Bui B Clin Med Insights Arthritis Musculoskelet Disord. 2024; 17:11795441241308876.

PMID: 39717067 PMC: 11664530. DOI: 10.1177/11795441241308876.


Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study.

Tidblad L, Westerlind H, Delcoigne B, Askling J, Saevarsdottir S RMD Open. 2023; 9(4).

PMID: 38123483 DOI: 10.1136/rmdopen-2023-003714.


Clinical Features Associated With Rate of Fractures in Patients With Systemic Sclerosis: A US Cohort Study.

Rogers B, Famenini S, Perin J, Danila M, Wipfler K, Michaud K Arthritis Care Res (Hoboken). 2023; 75(11):2379-2388.

PMID: 37093022 PMC: 10836612. DOI: 10.1002/acr.25137.


Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study.

Tidblad L, Westerlind H, Delcoigne B, Askling J, Saevarsdottir S RMD Open. 2022; 8(2).

PMID: 36564100 PMC: 9791425. DOI: 10.1136/rmdopen-2022-002700.


Hypoparathyroidism as one of the initial presentations of systemic lupus erythematosus.

Gadakchi L, Ebrahimi A, Sadra V, Moslemi M, Khabbazi A Clin Case Rep. 2022; 10(9):e6288.

PMID: 36093464 PMC: 9445256. DOI: 10.1002/ccr3.6288.